139 related articles for article (PubMed ID: 36434803)
1. Quantitative Radiomic Features From Computed Tomography Can Predict Pancreatic Cancer up to 36 Months Before Diagnosis.
Chen W; Zhou Y; Asadpour V; Parker RA; Puttock EJ; Lustigova E; Wu BU
Clin Transl Gastroenterol; 2023 Jan; 14(1):e00548. PubMed ID: 36434803
[TBL] [Abstract][Full Text] [Related]
2. Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
Chu LC; Park S; Kawamoto S; Fouladi DF; Shayesteh S; Zinreich ES; Graves JS; Horton KM; Hruban RH; Yuille AL; Kinzler KW; Vogelstein B; Fishman EK
AJR Am J Roentgenol; 2019 Aug; 213(2):349-357. PubMed ID: 31012758
[No Abstract] [Full Text] [Related]
3. Two nomograms for differentiating mass-forming chronic pancreatitis from pancreatic ductal adenocarcinoma in patients with chronic pancreatitis.
Zhang H; Meng Y; Li Q; Yu J; Liu F; Fang X; Li J; Feng X; Zhou J; Zhu M; Li N; Lu J; Shao C; Bian Y
Eur Radiol; 2022 Sep; 32(9):6336-6347. PubMed ID: 35394185
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.
Ren S; Zhao R; Zhang J; Guo K; Gu X; Duan S; Wang Z; Chen R
Abdom Radiol (NY); 2020 May; 45(5):1524-1533. PubMed ID: 32279101
[TBL] [Abstract][Full Text] [Related]
5. Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images.
Qureshi TA; Gaddam S; Wachsman AM; Wang L; Azab L; Asadpour V; Chen W; Xie Y; Wu B; Pandol SJ; Li D
Cancer Biomark; 2022; 33(2):211-217. PubMed ID: 35213359
[TBL] [Abstract][Full Text] [Related]
6. Radiomics-based Machine-learning Models Can Detect Pancreatic Cancer on Prediagnostic Computed Tomography Scans at a Substantial Lead Time Before Clinical Diagnosis.
Mukherjee S; Patra A; Khasawneh H; Korfiatis P; Rajamohan N; Suman G; Majumder S; Panda A; Johnson MP; Larson NB; Wright DE; Kline TL; Fletcher JG; Chari ST; Goenka AH
Gastroenterology; 2022 Nov; 163(5):1435-1446.e3. PubMed ID: 35788343
[TBL] [Abstract][Full Text] [Related]
7. Radiomic Features at CT Can Distinguish Pancreatic Cancer from Noncancerous Pancreas.
Chen PT; Chang D; Yen H; Liu KL; Huang SY; Roth H; Wu MS; Liao WC; Wang W
Radiol Imaging Cancer; 2021 Jul; 3(4):e210010. PubMed ID: 34241550
[TBL] [Abstract][Full Text] [Related]
8. CT Density in the Pancreas is a Promising Imaging Predictor for Pancreatic Ductal Adenocarcinoma.
Fukuda Y; Yamada D; Eguchi H; Hata T; Iwagami Y; Noda T; Asaoka T; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Mori M; Doki Y
Ann Surg Oncol; 2017 Sep; 24(9):2762-2769. PubMed ID: 28634666
[TBL] [Abstract][Full Text] [Related]
9. Radiomics model-based algorithm for preoperative prediction of pancreatic ductal adenocarcinoma grade.
Tikhonova VS; Karmazanovsky GG; Kondratyev EV; Gruzdev IS; Mikhaylyuk KA; Sinelnikov MY; Revishvili AS
Eur Radiol; 2023 Feb; 33(2):1152-1161. PubMed ID: 35986774
[TBL] [Abstract][Full Text] [Related]
10. Validation of Prognostic Radiomic Features From Resectable Pancreatic Ductal Adenocarcinoma in Patients With Advanced Disease Undergoing Chemotherapy.
Salinas-Miranda E; Khalvati F; Namdar K; Deniffel D; Dong X; Abbas E; Wilson JM; O'Kane GM; Knox J; Gallinger S; Haider MA
Can Assoc Radiol J; 2021 Nov; 72(4):605-613. PubMed ID: 33151087
[TBL] [Abstract][Full Text] [Related]
11. CT Abnormalities of the Pancreas Associated With the Subsequent Diagnosis of Clinical Stage I Pancreatic Ductal Adenocarcinoma More Than 1 Year Later: A Case-Control Study.
Toshima F; Watanabe R; Inoue D; Yoneda N; Yamamoto T; Sasahira N; Sasaki T; Matsuyama M; Minehiro K; Tateishi U; Gabata T
AJR Am J Roentgenol; 2021 Dec; 217(6):1353-1364. PubMed ID: 34161128
[No Abstract] [Full Text] [Related]
12. Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features.
Park S; Chu LC; Hruban RH; Vogelstein B; Kinzler KW; Yuille AL; Fouladi DF; Shayesteh S; Ghandili S; Wolfgang CL; Burkhart R; He J; Fishman EK; Kawamoto S
Diagn Interv Imaging; 2020 Sep; 101(9):555-564. PubMed ID: 32278586
[TBL] [Abstract][Full Text] [Related]
13. Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation.
Yamashita R; Perrin T; Chakraborty J; Chou JF; Horvat N; Koszalka MA; Midya A; Gonen M; Allen P; Jarnagin WR; Simpson AL; Do RKG
Eur Radiol; 2020 Jan; 30(1):195-205. PubMed ID: 31392481
[TBL] [Abstract][Full Text] [Related]
14. Application of Unenhanced Computed Tomography Texture Analysis to Differentiate Pancreatic Adenosquamous Carcinoma from Pancreatic Ductal Adenocarcinoma.
Ren S; Tang HJ; Zhao R; Duan SF; Chen R; Wang ZQ
Curr Med Sci; 2022 Feb; 42(1):217-225. PubMed ID: 35089491
[TBL] [Abstract][Full Text] [Related]
15. CT texture analysis for the presurgical prediction of superior mesenteric-portal vein invasion in pancreatic ductal adenocarcinoma: comparison with CT imaging features.
Chen F; Zhou Y; Qi X; Xia W; Zhang R; Zhang J; Gao X; Zhang L
Clin Radiol; 2021 May; 76(5):358-366. PubMed ID: 33581837
[TBL] [Abstract][Full Text] [Related]
16. Exploratory analysis of mesenteric-portal axis CT radiomic features for survival prediction of patients with pancreatic ductal adenocarcinoma.
Rigiroli F; Hoye J; Lerebours R; Lyu P; Lafata KJ; Zhang AR; Erkanli A; Mettu NB; Morgan DE; Samei E; Marin D
Eur Radiol; 2023 Aug; 33(8):5779-5791. PubMed ID: 36894753
[TBL] [Abstract][Full Text] [Related]
17. Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation.
Schima W; Böhm G; Rösch CS; Klaus A; Függer R; Kopf H
Cancer Imaging; 2020 Jul; 20(1):52. PubMed ID: 32703312
[TBL] [Abstract][Full Text] [Related]
18. Combining radiomic features with a miRNA classifier may improve prediction of malignant pathology for pancreatic intraductal papillary mucinous neoplasms.
Permuth JB; Choi J; Balarunathan Y; Kim J; Chen DT; Chen L; Orcutt S; Doepker MP; Gage K; Zhang G; Latifi K; Hoffe S; Jiang K; Coppola D; Centeno BA; Magliocco A; Li Q; Trevino J; Merchant N; Gillies R; Malafa M;
Oncotarget; 2016 Dec; 7(52):85785-85797. PubMed ID: 27589689
[TBL] [Abstract][Full Text] [Related]
19. Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis.
Marya NB; Powers PD; Chari ST; Gleeson FC; Leggett CL; Abu Dayyeh BK; Chandrasekhara V; Iyer PG; Majumder S; Pearson RK; Petersen BT; Rajan E; Sawas T; Storm AC; Vege SS; Chen S; Long Z; Hough DM; Mara K; Levy MJ
Gut; 2021 Jul; 70(7):1335-1344. PubMed ID: 33028668
[TBL] [Abstract][Full Text] [Related]
20. Clinical Features and Computed Tomography Radiomics-Based Model for Predicting Pancreatic Ductal Adenocarcinoma and Focal Mass-Forming Pancreatitis.
Ye Y; Zhang J; Song P; Qin P; Hu Y; An P; Li X; Lin Y; Wang J; Feng G
Technol Cancer Res Treat; 2023; 22():15330338231180792. PubMed ID: 37287274
[No Abstract] [Full Text] [Related]
[Next] [New Search]